Results 121 to 130 of about 2,690,172 (163)

Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity. [PDF]

Neuropsychopharmacology, 2023
Glazer J, Murray CH, Nusslock R, Lee R, de Wit H.   +4 more
europepmc   +1 more source

A randomised placebo-controlled study of the effects of lysergic acid diethylamide microdosing (15 μg) on pain perception in healthy volunteers. [PDF]

Br J Pain
Cavarra M, Hutten NRPW, Schepers J, Mason NL, Theunissen EL, Liechti ME, Kuypers KPC, Bonnelle V, Feilding A, Ramaekers JG.   +9 more
europepmc   +1 more source

Lysergic acid diethylamide induces increased signalling entropy in rats' prefrontal cortex. [PDF]

J Neurochem, 2022
Savino A, Nichols CD.
europepmc   +1 more source

Exploring Gender-Themed Lysergic Acid Diethylamide Experiences: A Subreddit Analysis. [PDF]

Psychedelic Med (New Rochelle)
Katkar R, Perez AM, Altinay M, Barnett BS.   +3 more
europepmc   +1 more source

Systems-level analysis of local field potentials reveals differential effects of lysergic acid diethylamide and ketamine on neuronal activity and functional connectivity. [PDF]

Front Neurosci, 2023
Nasretdinov A, Barrientos SA, Brys I, Halje P, Petersson P.   +4 more
europepmc   +1 more source

Perceived Availability of Lysergic Acid Diethylamide in the United States from 2015 to 2019. [PDF]

Psychedelic Med (New Rochelle)
Barnett BS, Anand A, Dewey EN, Hoffer L, Weleff J.   +4 more
europepmc   +1 more source

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. [PDF]

Neuropsychopharmacology, 2023
Ley L, Holze F, Arikci D, Becker AM, Straumann I, Klaiber A, Coviello F, Dierbach S, Thomann J, Duthaler U, Luethi D, Varghese N, Eckert A, Liechti ME.   +13 more
europepmc   +1 more source

Lysergic Acid Diethylamide (LSD) and the Heart: Exploring the Potential Impacts of LSD on Cardiovascular Function. [PDF]

Cureus
Suleria A, Verma S, Arya K, Stoltzfus MT, Gupta I, Singh B, Shaik T.   +6 more
europepmc   +1 more source

Pharmacokinetics and pharmacodynamics of sublingual microdosed lysergic acid diethylamide in healthy adult volunteers. [PDF]

J Psychopharmacol
Morse JD, Jeong SH, Murphy RJ, Muthukumaraswamy SD, Sumner RL.   +4 more
europepmc   +1 more source

Who Keeps Using Lysergic Acid Diethylamide? Correlates of Past-Year Use in People Who Initiated Use at least Five Years Ago. [PDF]

Psychedelic Med (New Rochelle)
Barnett BS, Anand A, Weleff J, King F, Dewey EN.   +4 more
europepmc   +1 more source